文献速递乳腺癌

荷兰乳腺癌患者十年条件复发风险及总生存与相对生存:考虑无事件生存年数

Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free years.
PubMed 文献 · Eur J Cancer · 2018-08-23

该研究基于荷兰癌症登记处2005年诊断的7969例手术T1-2N0-1乳腺癌患者,分析不同预后亚组的10年条件复发风险及调整混杂后的10年条件总生存(OS)和相对生存(RS)。结果显示随着诊断后无事件年数增加,各亚组复发率、OS和RS差异逐渐缩小,10年时所有复发率均≤1.5%。

要点

  • T1N0患者10年局部复发率从诊断时4.6%降至第10年0.5%,远处转移从7.8%降至0.6%。
  • T2N1患者10年局部复发率从6.2%降至0.8%,远处转移从19.6%降至1.5%。
  • 三阴性亚型远处转移率从16.7%降至0%,各亚组差异随时间缩小。

核心结论

  • 乳腺癌预后亚组间的复发率、总生存和相对生存差异随无事件生存年数增加而缩小。
  • 考虑无病生存年数可更准确预测(既往)乳腺癌患者的随时间变化的预后。

研究设计与样本

  • 基于荷兰癌症登记处,纳入2005年诊断且接受手术的T1-2N0-1乳腺癌女性7969例。
  • 按T1N0、T1N1、T2N0、T2N1分期分组,计算从诊断时及每年无事件后的10年条件复发率。
  • 采用多因素Cox回归计算10年条件总生存,相对生存通过患者生存率除以一般荷兰人群生存率估计。

主要发现

  • T1N0组10年局部复发率从诊断时4.6%降至第10年0.5%,区域复发从2.3%降至0.2%,远处转移从7.8%降至0.6%。
  • T2N1组10年局部复发率从6.2%降至0.8%,区域复发从5.2%降至0.4%,远处转移从19.6%降至1.5%。
  • Luminal A亚型局部复发从3.9%降至0.4%,区域复发从1.7%降至0.5%,远处转移从7.3%降至1.1%。
  • 三阴性亚型局部复发从5.6%降至0.7%,区域复发从4.9%降至0.2%,远处转移从16.7%降至0%。
  • 第10年时所有亚组的复发率均≤1.5%,调整混杂后OS和RS的亚组间风险差异随时间下降。

关键数值与推荐

  • T1N0组10年局部复发率4.6%→0.5%,区域复发2.3%→0.2%,远处转移7.8%→0.6%。
  • T2N1组10年局部复发率6.2%→0.8%,区域复发5.2%→0.4%,远处转移19.6%→1.5%。
  • Luminal A亚型10年局部复发3.9%→0.4%,区域复发1.7%→0.5%,远处转移7.3%→1.1%。
  • 三阴性亚型10年局部复发5.6%→0.7%,区域复发4.9%→0.2%,远处转移16.7%→0%。
  • 第10年所有复发率均≤1.5%。

临床怎么用

  • 对已无事件生存多年的乳腺癌患者,应基于条件生存(考虑无病年数)而非诊断时生存估计进行预后咨询。
  • 随无事件年数增加,不同分期和亚型间的复发风险差异缩小,可据此调整随访强度和干预策略。

局限性

  • 研究仅纳入2005年诊断的患者,治疗模式和诊断技术可能已发生变化。
  • 回顾性登记数据可能存在混杂因素未完全调整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Survival estimates from diagnosis are of limited importance for (ex-)breast cancer patients who survived several years, as it includes information on already deceased patients. This study analysed the 10-year conditional risk of recurrent breast cancer in specific prognostic subgroups. Second, we investigated 10-year conditional overall survival (OS) and relative survival (RS), adjusted for confounding. PATIENTS AND METHODS: All women diagnosed in 2005 with operated T1-2N0-1 breast cancer were selected from the Netherlands Cancer Registry. Patients were classified into T1N0, T1N1, T2N0 and T2N1 stage. Ten-year conditional recurrence rates were calculated from diagnosis, and for patients without an event (local [LR], regional recurrence [RR], distant metastasis [DM] or death) every year following diagnosis. Ten-year conditional OS was calculated using multivariable Cox regression. RS was estimated by dividing patient survival rates by those of the general Dutch population. RESULTS: We included 7969 patients: 52.3% had T1N0, 15.3% T1N1, 19.9% T2N0 and 12.5% T2N1 stage. For T1N0, 10-year LR rates changed from 4.6% at diagnosis to 0.5% in year 10. RR rates changed from 2.3% to 0.2%, and DM rates changed from 7.8% to 0.6%. For T2N1 stage, the LR, RR and DM rates changed from 6.2% to 0.8%, 5.2%-0.4% and 19.6%-1.5%, respectively. For the luminal A subtype, LR, RR and DM rates changed from 3.9% to 0.4%, 1.7%-0.5% and 7.3%-1.1%, while for triple negative, these rates changed from 5.6% to 0.7%, 4.9%-0.2% and 16.7%-0%, respectively. Differences between subgroups attenuated over time, and all recurrence rates became ≤1.5% in year 10. Ten-year OS and RS, adjusted for confounding, showed declining risk differences between subgroups over time. CONCLUSION: Differences in recurrence rates, OS and RS between prognostic subgroups declined as years passed by. These results highlight the importance of taking into account disease-free years to more accurately predict (ex-)breast cancer patients' prognosis over time.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. van Maaren MC, Strobbe LJA, Smidt ML, et al. Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free years. Eur J Cancer. 2018. PMID: 30144661. doi:10.1016/j.ejca.2018.07.124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。